[A18-83] Ezetimibe for the prevention of cardiovascular Events - Rapid report
Last updated 05.09.2019
Project no.:
A18-83
Commission:
Commission awarded on 27.11.2018 by the Federal Joint Committee (G-BA).
Report type:
Rapid report
Status:
Commission completed
Department/Division:
Drug Assessment
Application field:
Digestion, metabolism and hormones
Note:
The present version 2.0 of 3 September 2019 replaces version 1.0 of the rapid report of 28 June 2019. There have been changes in the risk of bias for the outcome “serious cardiovascular events”.